Navigation Links
Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress

approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.

About GPC Biotech

GPC Biotech AG is a biopharmaceutical company discovering and developing new anticancer drugs. GPC Biotech's lead product candidate -- satraplatin -- has achieved target enrollment in a Phase 3 registrational trial as a second-line chemotherapy treatment in hormone-refractory prostate cancer. The U.S. FDA has granted fast track designation to satraplatin for this indication, and GPC Biotech has completed the rolling NDA submission process for this compound. GPC Biotech is also developing a monoclonal antibody with a novel mechanism-of-action against a variety of lymphoid tumors, currently in Phase 1 clinical development, and has ongoing drug development and discovery programs that leverage its expertise in kinase inhibitors. GPC Biotech AG is headquartered in Martinsried/Munich (Germany), and its wholly owned U.S. subsidiary has sites in Waltham, Massachusetts and Princeton, New Jersey. For additional information, please visit GPC Biotech's Web site at http://www.gpc-biotech.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This press release contains forward-looking statements, which express the current beliefs and expectations of the management of GPC Biotech AG and Pharmion Corporation, including statements relating to results of the SPARC trial and statements relating to the potential efficacy and safety profile of satraplatin. Such statements are based on current expectations and are subject to risks and uncertainties, many of which are beyond our control, that could cause future results, performance or achievements to differ significantly from the results, performance or achievements expressed or im
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
Post Your Comments:
(Date:12/17/2014)... -- Revenue and earnings above the previous year ... In the past 2013/14 fiscal year (ended 30 ... EUR 4.287 billion (last year: EUR 4.190 billion) despite unfavorable ... 360 million. "Overall, 2013/14 was a successful fiscal year for ... and CEO of Carl Zeiss AG. "Thanks to our broad ...
(Date:12/17/2014)... With advancements in neurological and functional ... seeing new growth, according to Kalorama Information. Though ... the majority of market volume, newer 3T systems ... are creating opportunities for more sophisticated applications. The medical ... a rate of 4%, with world market revenues ...
(Date:12/17/2014)... , Dec. 17, 2014  ImmunoCellular Therapeutics, ... US Patent and Trademark Office (USPTO) has issued ... a dendritic cell-based immunotherapeutic vaccine targeting six tumor ... claims of US Patent No. 8,871,211, which issued ... cancer by administering a dendritic cell composition comprising ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... May 19 ImaginAb, Inc. and the GSK Clinical Imaging Centre ... agreements around a clinical therapeutic antibody asset currently under development by GSK ... , , ... CIC," said Dr. Christian Behrenbruch , CEO of ImaginAb. "Not only ...
... 19 ... only conference dedicated to addressing the challenges facing the ... Medical Product Outsourcing magazine, invites OEM professionals and ... agenda and extraordinary lineup of speakers. Detailed registration and ...
Cached Medicine Technology:ImaginAb, Inc. and GlaxoSmithKline Establish Collaboration 2Medical Product Outsourcing Magazine Announces the First Annual CardioTec Conference 2Medical Product Outsourcing Magazine Announces the First Annual CardioTec Conference 3
(Date:12/19/2014)... warns parents that buying an older car for their teens may ... drivers killed in the United States between 2008 and 2012 were ... lacked important safety features that are available on newer cars, the ... were in cars at least six years old, 34 percent were ... cars 11 to 15 years old, and 17 percent were in ...
(Date:12/19/2014)... News) -- Dense bunches of bacteria called biofilms can be ... finds. The researchers said these biofilms were especially ... presence of these biofilms may represent an increased likelihood of ... a person,s risk for the disease, the researchers said. ... may coat the mucus layer of cells lining the colon, ...
(Date:12/19/2014)... HealthDay Reporter THURSDAY, ... the United States -- along with Angelina Jolie,s chickenpox ... highlighted cracks in the nation,s public health defense against ... released Thursday. Half of U.S. states are poorly ... outbreaks. That was the main conclusion of the report ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 Hands On Mobile ... available. The Spa On Wheels has been transformed into ... from the outside world seems to disappear. The Virtual Tour ... massages, facials, spa parties, corporate events and more. , The ... Spa On Wheels which is actually an overhauled Winnebago. Marla ...
(Date:12/19/2014)... After a 13-year absence from active touring, ... the stage to entertain his many worldwide fans. Trisha ... the successful tour has been steadily expanding since the ... Ticketability.com for a large inventory of Garth ... prices. , Music fans have had a long wait ...
Breaking Medicine News(10 mins):Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Could Bacteria Play a Role in Colon Cancer? 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2
... Surgeons ... Annual Clinical Congress -, PALO ALTO, ... developing novel radiofrequency tissue dissection,instrumentation, today announced results from a ... of surgical,incisions compared with standard electrosurgery and surgical scalpels.,Results showed ...
... Demo Introduces Arthritis and Injury Sufferers to All-Natural Pain ... ... All pain creams are not,created equal. Many use alcohol and paraben ... pain, without attacking underlying,inflammation. To get the word out about true pain ...
... of Plan to Give Access to Affordable Health ... one week,after Cover All Pennsylvanians, the centerpiece of ... Governor Edward G.,Rendell today kicked off a statewide ... The five-day, nine-stop tour will highlight the,need to ...
... people with disabilities control a computer cursor without lifting a ... Vocal Joystick would have as much control as someone using ... with disabilities. But many of those same people find it ... at the University of Washington provides an alternative using one ...
... 80%, researchers say , , TUESDAY, Oct. 9 (HealthDay News) -- ... stroke or transient ischemic attack (TIA, or "mini-stroke") cuts their ... new studies find. , A TIA causes symptoms similar to ... disappear within several hours. , The first study, by British ...
... LLC has furthered its,movement in helping to raise awareness ... of its Coupon Codes for a Cure Campaign,MyCoupons.com has ... among web,retailers. MyCoupons.com recently announced that they will ... redeem coupons from their site,with thousands of online retail ...
Cached Medicine News:Health News:PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM) 2Health News:PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM) 3Health News:MyoMed Launches Flash Virtual Tour of Toxin-Free Pain Relief 2Health News:Governor Rendell Launches 'Tour to Insure;' 2Health News:Governor Rendell Launches 'Tour to Insure;' 3Health News:Generating 'oohs' and 'aahs': Vocal Joystick uses voice to surf the Internet 2Health News:Generating 'oohs' and 'aahs': Vocal Joystick uses voice to surf the Internet 3Health News:Speedy 'Mini-Stroke' Care Pays Off 2Health News:MyCoupons, LLC Enlists Clients into the Fight Against Breast Cancer 2
... for biological safety labs (BSL) and ... Class 10/ISO 3) and easy sterilization. ... surfaces that are easy to wipe ... simplify cleaning. Unique double-wall panel design ...
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
Inquire...
Inquire...
Medicine Products: